-
Mashup Score: 0Initial Impressions and Comparison to Typical Cases - 11 hour(s) ago
Dr. Bose discusses his initial impressions of the case and how it compares to typical myelofibrosis cases seen in his practice.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Cell Therapies Emerge for the Treatment of Acute Myeloid Leukemia - 15 hour(s) ago
Cellular therapies are an effective option in hematologic malignancies but have been slower to develop in AML, but identifying new targets paves the way for evolving treatments.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet-
Cellular therapies have emerged as effective treatments for hematologic malignancies, yet progress in applying them to #AML lags behind. However, identifying new targets is driving innovation. @Daver_Leukemia @MusaYilmazMD @MDAndersonNews @StJudeResearch https://t.co/4qm32wr2l8 https://t.co/8ArowVHKCr
-
-
Mashup Score: 1Updates on the iNTEGRATE and ROCKstar Trials - 17 hour(s) ago
Yi-Bin Chen, MD, provides an overview of the iNTEGRATE and ROCKstar trials, underscoring their significance in the current treatment paradigm for graft versus host disease, particularly highlighting their ability to inhibit the fibrosis cascade, which offers substantial benefits for patient healing and recovery.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2
Ira Zackon, MD, discusses the background of a real-world study which sought to identify some of the racial and socioeconomic disparities seen in patients with chronic lymphocytic leukemia.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Exploring the Link Between HPV Infection and Head and Neck Cancers - 20 hour(s) ago
In an interview with Targeted Oncology for Head and Neck Cancer Awareness Month, Noel Laudi, MD, MRCP, discussed the link between human papillomavirus infection and head and neck cancers.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Lessons Learned from REACH-3 Clinical Trial - 1 day(s) ago
Yi-Bin Chen, MD, presents the results of the phase-3 randomized REACH-3 Trial, highlighting the superior best overall response rate of 75% in the experimental arm compared to 60% in the best-available therapy arm.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Lenvatinib Is Effective, Regardless of Age in HCC - 2 day(s) ago
No differences in efficacy and safety were seen in a study cohort of 1325 patients undergoing frontline treatment with lenvatinib for unresectable hepatocellular carcinoma.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Tina Cascone, MD, PhD, discusses the CheckMate-77T trial of perioperative regimen of neoadjuvant nivolumab plus chemotherapy followed by surgery and adjuvant nivolumab for the treatment of patients with stage IIA to IIIB non-small cell lung cancer.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
Following its recent FDA approval in non-muscle-invasive bladder cancer, nogapendekin alfa has also shown overall survival benefits in addition to checkpoint inhibitor therapy in patients with non-small cell lung cancer.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3
In an interview with Targeted Oncology, Ben Jones identified the key challenges community oncologists are facing due to legislative changes in cancer care policy.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
Prithviraj Bose, MD, of @MDAndersonNews discusses his initial impressions of the case and how it compares to typical #myelofibrosis cases seen in his practice. https://t.co/SWowCkLXYm